Profile | GDS4284 / 1557197_a_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 121.341 | 40 |
GSM687648 | Patient 402 control | 68.7299 | 28 |
GSM687653 | Patient 403 control | 46.7631 | 23 |
GSM687658 | Patient 404 control | 146.23 | 42 |
GSM687663 | Patient 411 control | 199.444 | 47 |
GSM687668 | Patient 422 control | 128.145 | 40 |
GSM687673 | Patient 424 control | 147.143 | 41 |
GSM687678 | Patient 425 control | 13.5851 | 7 |
GSM687683 | Patient 427 control | 269.399 | 52 |
GSM687688 | Patient 428 control | 130.233 | 40 |
GSM687695 | Patient 441 control | 268.088 | 46 |
GSM687699 | Patient 443 control | 155.364 | 39 |
GSM687704 | Patient 444 control | 87.4324 | 32 |
GSM687707 | Patient 448 control | 196.923 | 44 |
GSM687712 | Patient 449 control | 114.603 | 37 |
GSM687719 | Patient 450 control | 225.688 | 47 |
GSM687724 | Patient 451 control | 195.03 | 45 |
GSM687728 | Patient 452 control | 80.4465 | 28 |
GSM687646 | Patient 401 treated 24h | 108.759 | 36 |
GSM687649 | Patient 402 treated 24h | 56.0595 | 26 |
GSM687665 | Patient 411 treated 24h | 170.827 | 43 |
GSM687651 | Patient 402 treated 4 weeks | 125.596 | 38 |
GSM687667 | Patient 411 treated 4 weeks | 131.097 | 39 |
GSM687670 | Patient 422 treated 24h | 78.8895 | 29 |
GSM687671 | Patient 422 treated 4 weeks | 175.063 | 47 |
GSM687654 | Patient 403 treated 24h | 84.6703 | 34 |
GSM687675 | Patient 424 treated 24h | 62.9438 | 24 |
GSM687685 | Patient 427 treated 24h | 119.012 | 37 |
GSM687656 | Patient 403 treated 4 weeks | 95.3692 | 36 |
GSM687677 | Patient 424 treated 4 weeks | 70.4395 | 28 |
GSM687687 | Patient 427 treated 4 weeks | 82.9185 | 33 |
GSM687692 | Patient 428 treated 4h | 154.412 | 43 |
GSM687716 | Patient 449 treated 4h | 151.656 | 43 |
GSM687722 | Patient 450 treated 4h | 79.2 | 27 |
GSM687680 | Patient 425 treated 24h | 115.026 | 37 |
GSM687690 | Patient 428 treated 24h | 81.2483 | 31 |
GSM687700 | Patient 443 treated 24h | 131.41 | 32 |
GSM687705 | Patient 444 treated 24h | 256.373 | 54 |
GSM687714 | Patient 449 treated 24h | 73.6676 | 30 |
GSM687721 | Patient 450 treated 24h | 129.404 | 35 |
GSM687682 | Patient 425 treated 4 weeks | 118.805 | 39 |
GSM687694 | Patient 428 treated 4 weeks | 71.6695 | 30 |
GSM687702 | Patient 443 treated 4 weeks | 224.669 | 48 |
GSM687718 | Patient 449 treated 4 weeks | 139.281 | 41 |
GSM687723 | Patient 450 treated 4 weeks | 160.609 | 42 |
GSM687661 | Patient 404 treated 4h | 153.259 | 42 |
GSM687710 | Patient 448 treated 4h | 110.878 | 36 |
GSM687726 | Patient 451 treated 4h | 212.262 | 47 |
GSM687730 | Patient 452 treated 4h | 664.066 | 64 |
GSM687660 | Patient 404 treated 24h | 111.235 | 31 |
GSM687697 | Patient 441 treated 24h | 267.793 | 49 |
GSM687709 | Patient 448 treated 24h | 125.549 | 37 |
GSM687725 | Patient 451 treated 24h | 379.215 | 58 |
GSM687729 | Patient 452 treated 24h | 71.6781 | 23 |
GSM687727 | Patient 451 treated 4 weeks | 206.388 | 46 |
GSM687731 | Patient 452 treated 4 weeks | 205.45 | 46 |